Latest Episodes
How 200 Snake Bites Became a Universal Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax
This week on BioTech Nation, a call to a man who survived hundreds of venomous snake bites helps inspire the development of an antivenom vaccine. Biotech Entrepreneur,...
Hospital at Home? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's BioTech Nation, Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the trend of "hospital-at-home". As we see the expansion of remot...
A Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology
On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's unique approach to cancer immunotherapy, and how a d...
Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals
On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for the treatment of acute myeloid leukemia and graft v...
Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics
On this episode of BioTech Nation, Dan Schmitt of Actuate Therapeutics talks about a new kind of drug showing positive early results in hard-to-treat cancer - includin...
